HK1065070A1 - Viral drug susceptibility testing - Google Patents
Viral drug susceptibility testingInfo
- Publication number
- HK1065070A1 HK1065070A1 HK04106865A HK04106865A HK1065070A1 HK 1065070 A1 HK1065070 A1 HK 1065070A1 HK 04106865 A HK04106865 A HK 04106865A HK 04106865 A HK04106865 A HK 04106865A HK 1065070 A1 HK1065070 A1 HK 1065070A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- susceptibility testing
- drug susceptibility
- viral drug
- viral
- testing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/25—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving enzymes not classifiable in groups C12Q1/26 - C12Q1/66
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
- G01N2333/08—RNA viruses
- G01N2333/15—Retroviridae, e.g. bovine leukaemia virus, feline leukaemia virus, feline leukaemia virus, human T-cell leukaemia-lymphoma virus
- G01N2333/155—Lentiviridae, e.g. visna-maedi virus, equine infectious virus, FIV, SIV
- G01N2333/16—HIV-1, HIV-2
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/91—Transferases (2.)
- G01N2333/912—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
- G01N2333/91205—Phosphotransferases in general
- G01N2333/91245—Nucleotidyltransferases (2.7.7)
- G01N2333/9125—Nucleotidyltransferases (2.7.7) with a definite EC number (2.7.7.-)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/04—Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Analytical Chemistry (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US29776401P | 2001-06-14 | 2001-06-14 | |
PCT/SE2002/001156 WO2002103040A1 (en) | 2001-06-14 | 2002-06-14 | Viral drug susceptibility testing |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1065070A1 true HK1065070A1 (en) | 2005-02-08 |
Family
ID=23147646
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK04106865A HK1065070A1 (en) | 2001-06-14 | 2004-09-10 | Viral drug susceptibility testing |
Country Status (18)
Country | Link |
---|---|
US (1) | US7875422B2 (zh) |
EP (1) | EP1395676B1 (zh) |
JP (1) | JP4455054B2 (zh) |
CN (1) | CN1539022B (zh) |
AP (1) | AP1592A (zh) |
AT (1) | ATE316150T1 (zh) |
AU (1) | AU2002309447B2 (zh) |
BR (1) | BRPI0210361B8 (zh) |
DE (1) | DE60208788T2 (zh) |
EA (1) | EA006161B1 (zh) |
ES (1) | ES2257553T3 (zh) |
HK (1) | HK1065070A1 (zh) |
MX (1) | MXPA03011564A (zh) |
OA (1) | OA12620A (zh) |
PL (1) | PL209075B1 (zh) |
PT (1) | PT1395676E (zh) |
WO (1) | WO2002103040A1 (zh) |
ZA (1) | ZA200309551B (zh) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2016523088A (ja) * | 2013-06-26 | 2016-08-08 | フィロジカ リミテッドPhylogica Limited | ペプチドの細胞輸送をモニタリングする方法 |
BR112019027993A2 (pt) * | 2017-07-04 | 2020-07-07 | Cavidi Ab | métodos para avaliar a susceptibilidade de um vírus ao tratamento com um fármaco inibidor de uma enzima do vírus do tipo selvagem, para avaliar se um paciente tratado para uma infecção viral tem necessidade de alterar a terapia farmacológica com um fármaco inibidor da enzima viral e para determinar a carga de um vírus em uma amostra do paciente e a dita resistência do vírus ao tratamento com um fármaco inibidor de uma enzima do vírus do tipo selvagem, e, sistema |
CN108896759B (zh) * | 2018-06-27 | 2020-05-19 | 南京医科大学 | 受试物致敏性检测方法及其试剂盒 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4707439A (en) * | 1984-10-26 | 1987-11-17 | The United States Of America As Represented By The Department Of Health And Human Services | Screening test for reverse-transcriptase containing virus such as non-A, non-B hepatitis, NANBH |
EP0707635A1 (de) | 1993-06-01 | 1996-04-24 | FAFF, Ortwin | Verfahren zum direkten und biochemisch funktionellen nachweis von retroviren in biologischen proben |
DE19608687A1 (de) | 1996-03-06 | 1997-09-11 | Retro Tech Gmbh | Verfahren und Test-Kit für den nichtradioaktiven, enzymatischen Nachweis von Reverser Transkriptase |
SE9902410D0 (sv) * | 1999-06-24 | 1999-06-24 | Cavidi Tech Ab | Reverse transcriptase assay kit, use thereof and method for analysis of RT activity in biological samples |
SE0001132D0 (sv) | 2000-03-29 | 2000-03-29 | Cavidi Tech Ab | Method of concentrating and recovering a viral enzyme activity from biological samples |
-
2002
- 2002-06-14 BR BRPI0210361A patent/BRPI0210361B8/pt not_active IP Right Cessation
- 2002-06-14 EP EP02736442A patent/EP1395676B1/en not_active Expired - Lifetime
- 2002-06-14 DE DE60208788T patent/DE60208788T2/de not_active Expired - Lifetime
- 2002-06-14 MX MXPA03011564A patent/MXPA03011564A/es active IP Right Grant
- 2002-06-14 AP APAP/P/2003/002923A patent/AP1592A/en active
- 2002-06-14 EA EA200301244A patent/EA006161B1/ru not_active IP Right Cessation
- 2002-06-14 AT AT02736442T patent/ATE316150T1/de not_active IP Right Cessation
- 2002-06-14 AU AU2002309447A patent/AU2002309447B2/en not_active Ceased
- 2002-06-14 ES ES02736442T patent/ES2257553T3/es not_active Expired - Lifetime
- 2002-06-14 CN CN028155971A patent/CN1539022B/zh not_active Expired - Fee Related
- 2002-06-14 PL PL367829A patent/PL209075B1/pl unknown
- 2002-06-14 WO PCT/SE2002/001156 patent/WO2002103040A1/en active IP Right Grant
- 2002-06-14 JP JP2003505361A patent/JP4455054B2/ja not_active Expired - Fee Related
- 2002-06-14 PT PT02736442T patent/PT1395676E/pt unknown
- 2002-06-14 US US10/479,511 patent/US7875422B2/en active Active
- 2002-06-14 OA OA1200300318A patent/OA12620A/en unknown
-
2003
- 2003-12-09 ZA ZA2003/09551A patent/ZA200309551B/en unknown
-
2004
- 2004-09-10 HK HK04106865A patent/HK1065070A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
BRPI0210361B8 (pt) | 2021-07-27 |
CN1539022A (zh) | 2004-10-20 |
PL209075B1 (pl) | 2011-07-29 |
CN1539022B (zh) | 2011-04-13 |
EP1395676B1 (en) | 2006-01-18 |
EA006161B1 (ru) | 2005-10-27 |
JP2004530433A (ja) | 2004-10-07 |
EA200301244A1 (ru) | 2004-06-24 |
BR0210361B1 (pt) | 2014-12-30 |
AU2002309447B2 (en) | 2007-05-24 |
ES2257553T3 (es) | 2006-08-01 |
PT1395676E (pt) | 2006-06-30 |
US20040170958A1 (en) | 2004-09-02 |
US7875422B2 (en) | 2011-01-25 |
DE60208788T2 (de) | 2006-11-09 |
WO2002103040A1 (en) | 2002-12-27 |
AP1592A (en) | 2006-03-20 |
AP2003002923A0 (en) | 2003-12-31 |
BR0210361A (pt) | 2004-06-22 |
MXPA03011564A (es) | 2004-03-18 |
JP4455054B2 (ja) | 2010-04-21 |
EP1395676A1 (en) | 2004-03-10 |
DE60208788D1 (de) | 2006-04-06 |
OA12620A (en) | 2006-06-12 |
ZA200309551B (en) | 2005-02-23 |
ATE316150T1 (de) | 2006-02-15 |
PL367829A1 (en) | 2005-03-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1068812A1 (en) | Drug preparations | |
PT1379220E (pt) | Capsulas de inalacao | |
GB0104534D0 (en) | Pharmaceutical combination | |
PL366510A1 (en) | Pharmaceutical combinations | |
GB0124523D0 (en) | Pharmaceutical combination | |
GB0129596D0 (en) | Risk detection | |
ZA200309551B (en) | Viral drug susceptibility testing | |
GB0128310D0 (en) | Test | |
GB0129270D0 (en) | Pharmaceutical combination | |
GB0129397D0 (en) | Pharmaceutical combination | |
GB0129872D0 (en) | Novel pharmaceutical | |
GB0129395D0 (en) | Pharmaceutical combination | |
GB2371592B (en) | Measure | |
GB0128138D0 (en) | Pharmaceutical use | |
GB0100752D0 (en) | Drug testing | |
GB0106352D0 (en) | Shake-resistant fixing peg | |
GB0124483D0 (en) | Vial integrity test | |
GB0130511D0 (en) | Novel pharmaceutical | |
GB0130510D0 (en) | Novel pharmaceutical | |
GB0130509D0 (en) | Novel pharmaceutical | |
GB0129876D0 (en) | Novel pharmaceutical | |
GB0000906D0 (en) | Drug testing | |
GB0129871D0 (en) | Novel pharmaceutical | |
GB0127358D0 (en) | Pharmaceutical use | |
GB0200612D0 (en) | Drug testing |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20210614 |